Publication | Closed Access

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

Non-small-cell Lung CancerMedicineMetronomic TherapyClinical TrialsBronchial NeoplasmAtezolizumab Versus DocetaxelPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences